With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|CD19 Delta Ex2 Isoform as a Target for Alternative Therapies in Relapsed Pediatric B-ALL||Children's Hospital of Philadelphia / Asen Bagashev, PhD||Young Investigator Grants||2016||Pennsylvania|
|Resistance and Develop Improved Treatments for Relapsed/refractory Pediatric ALL||Dana-Farber Cancer Institute / Elizabeth Townsend, PhD||Young Investigator Grants||2016||Massachusetts|
|A CRISPRi Genetic Screen in Ewing sarcoma Identifies a Novel Dependence on Homologous Recombination DNA Repair||University of California San Francisco / Asmin Tulpule, MD/PhD||Young Investigator Grants||2016||California|
|Micro-environmental Regulators of Ewing sarcoma Metastasis||University of Pittsburgh / Kelly Bailey, MD/PhD||Young Investigator Grants||2016||Pennsylvania|
|Targeting Eya2 to Inhibit c-Myc driven Medulloblastoma Tumor Progression||University of Colorado Denver / Melanie Vincent, PhD||Young Investigator Grants||2016||Colorado|
|Developing Targeted Immunotherapy Against Pediatric Acute Myeloid Leukemia||Fred Hutchinson Cancer Research Center / Melinda Biernacki, MD||Young Investigator Grants||2016||Washington|
|Investigating Racial Disparities in Pediatric Acute Leukemia||University of California San Francisco / Lena Winestone, MD||Young Investigator Grants||2016||California|
|GPC2 as an Oncogene and Immunotherapeutic Target in High-risk Neuroblastoma||Children's Hospital of Philadelphia / Kristopher Bosse, MD||Young Investigator Grants||2016||Pennsylvania|
|Identification of Mechanisms of Resistance to Trametinib Monotherapy in PAX-fusion Negative Rhabdomyosarcoma||National Cancer Institute / Marielle Yohe, MD/PhD||Young Investigator Grants||2016||Maryland|
|The Role of MiRNA Impairment in Wilms' Tumor Formation||University of Texas Southwestern Medical Center at Dallas / Kenneth Chen, MD||Young Investigator Grants||2016||Texas|